arrow
M

Michael Brundage

queen's university
H指数:66
被引数:1.7万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Reporting health-related quality of life in randomised clinical trials evaluating adjuvant systemic therapy: recommendations of Common-Sense Oncology and the European Organisation for Research and Treatment of Cancer

报告辅助全身治疗随机临床试验中的健康相关生活质量:常识肿瘤学和欧洲癌症研究与治疗组织的建议

2026-09-290
PRE
A randomized Phase II trial of High Dose-Rate (HDR) and Low Dose-Rate (LDR) brachytherapy as monotherapy in localized prostate cancer: analysis of initial arms of Canadian cancer trials group PR19 (NCT02960087)

一项关于高剂量率(HDR)和低剂量率(LDR)近距离治疗作为单一疗法在局限性前列腺癌中的随机Ⅱ期试验:加拿大癌症试验组PR19(NCT02960087)初始试验组的分析

2025-09-080
PRE
Importance of responder criteria for reporting health-related quality-of-life data in clinical trials for advanced cancer: recommendations of Common Sense Oncology and the European Organisation for Research and Treatment of Cancer

在晚期癌症临床试验中报告与健康相关的生活质量数据时,应答者标准的重要性:常识肿瘤学与欧洲癌症研究与治疗组织的建议

2025-09-010
PRE
A Framework to Promote Implementation of Patient-Reported Outcomes in Institutions Caring for Vulnerable and Underserved Cancer Populations
2024-06-222
PRE
Recommendations to address respondent burden associated with patient-reported outcome assessment
2024-02-2919
OA